Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 17, 2018 at 9:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Nov 21, 2001
    Likes Received:
    via On the heels of the FDA lifting its clinical hold on lead product BPX-501, Bellicum announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All shares of common stock to be sold in the offering will be offered by Bellicum.

    article source